Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank
11th August 2023 • Oncology Today with Dr Neil Love • Research To Practice
00:00:00
02:48:57